- Home
- Our Services
- Medical Device & IVD
- CE Marking
Our Services
CE Marking for Medical Devices
CE marking for medical devices is a mandatory EU regulatory certification that proves a device meets European safety, health, and performance standards under EU MDR 2017/745. Without it, no medical device can legally be sold in the EU. It applies to everything from simple bandages to complex pacemakers — and covers manufacturers from any country, including India.
What Does CE Mean in Medical Terms?
CE stands for Conformité Européenne — French for ‘European Conformity.’ In medical contexts, CE meaning is straightforward: it is legal proof that your device meets all EU health and safety laws.
The CE mark is NOT a quality award. It is a regulatory passport. It does not mean your device is the best — it means your device is legal.
Think of it this way: a CE mark is to the EU market what BIS certification is to India or FDA clearance is to the United States. Without it, EU customs will stop your shipment.
Who Needs CE Certification for Medical Devices?
CE marking for medical devices is required for any company — regardless of location — that wants to place a medical device on the European market. This includes:
- Manufacturers who design and produce the device (even if based in India, China, or the US)
- EU importers and distributors who place devices on the EU market under their own name
- Companies that substantially modify a CE-marked device or repack/relabel it for the EU market
- Authorized Representatives acting on behalf of a non-EU manufacturer
If you are an Indian manufacturer exporting to Germany, France, the Netherlands, or any EU country — CE marking is non-negotiable. You also need to appoint an EU Authorized Representative before you can begin the process.
Medical Device Classification Under EU MDR: The Foundation of Everything
This is where most manufacturers make their first — and costliest — mistake. Getting your device classification wrong can mean spending money on the wrong type of conformity assessment, or worse, having your CE mark rejected or withdrawn.
Under EU MDR 2017/745, devices are classified into four risk-based categories using 22 classification rules in Annex VIII:
| Class | Risk Level | Examples | Notified Body? | Approx. Timeline |
|---|---|---|---|---|
| Class I | Low | Bandages, crutches, non-sterile gloves, spectacle frames | No (self-declaration) | 3 – 6 months |
| Class I (s/m/r) | Low-Med | Sterile Class I, Class I with measuring function, reusable surgical instruments | Yes (limited scope) | 6 – 12 months |
| Class IIa | Medium | Dental fillings, short-term implants, hearing aids, pregnancy tests | Yes | 9 – 18 months |
| Class IIb | Medium-High | Ventilators, X-ray machines, long-term contact lenses, infusion pumps | Yes | 12 – 24 months |
| Class III | High | Cardiac stents, pacemakers, spinal implants, brain stimulators | Yes + Clinical Trials | 2 – 5 years |
CE Marking Process for Medical Devices: Complete Step-by-Step
Here is the full process — not a simplified version. Every step matters, and skipping any one of them can result in Notified Body rejection or EU market withdrawal.
Step 1: Classify Your Device (EU MDR Annex VIII)
Use the 22 classification rules in EU MDR Annex VIII. The classification depends on: intended purpose, invasiveness, duration of body contact, whether the device is active or passive, and whether it uses a substance that is absorbed by the body.
Do not rely on how the device was classified under the old MDD. EU MDR has new rules that have moved many devices into higher-risk classes.
Step 2: Identify All Applicable Harmonized Standards
Harmonized standards provide a technical shortcut. If your device fully meets a harmonized standard, you get a ‘presumption of conformity’ with the corresponding EU MDR requirement.
Key standards to identify early:
- ISO 13485:2016 — Quality Management Systems for medical devices
- ISO 14971:2019 — Risk management for medical devices
- IEC 62304:2006+AMD1:2015 — Medical device software lifecycle processes
- EN ISO 10993 series — Biological evaluation of medical devices
- EN 62133 — Battery safety for portable devices
- EN 60601-1 — Electrical safety for medical electrical equipment
Step 3: Build Your Quality Management System (ISO 13485)
A QMS is the organizational spine behind CE marking. It controls how your devices are designed, manufactured, tested, released, and monitored. ISO 13485 certification demonstrates that your QMS meets international medical device quality standards.
What a solid QMS must cover:
- Design and development controls
- Document and record management
- Supplier evaluation and control
- Non-conformance management and CAPA
- Complaint handling and post-market feedback
- Internal audits and management review
Step 4: Compile Technical Documentation
The Technical File (or Design Dossier for Class III) is the heart of your CE submission. It is what the Notified Body reviews. It must be complete, traceable, and defensible.
Required content of a Technical File:
- Device description, intended purpose, and target patient population
- Device identification: model name, product code, variants
- Design and manufacturing information
- Essential performance and safety requirements (GSPR checklist from EU MDR Annex I)
- Risk management file (per ISO 14971 — including residual risks and risk-benefit analysis)
- Pre-clinical and clinical evaluation data
- Labelling and Instructions for Use (IFU) in all required EU languages
- Post-Market Surveillance (PMS) plan
- Summary of Safety and Clinical Performance (SSCP) — for Class III and implantable Class IIb
Step 5: Appoint an EU Authorized Representative
This step is mandatory for all non-EU manufacturers. An EU Authorized Representative (EU AR) is a legal entity registered in an EU member state. They register your device in EUDAMED, act as the regulatory contact for EU authorities, and are jointly liable for compliance.
Important: the EU AR is not just a box to tick. They have real legal responsibilities. Choose one with actual medical device regulatory experience.
Step 6: Conduct Clinical Evaluation
Clinical evaluation is the process of gathering, analysing, and assessing clinical data to confirm that your device achieves its intended purpose and is safe when used as intended.
Clinical evidence can come from:
- Clinical investigations (trials) conducted by you
- Published clinical data from equivalent devices in literature
- Post-market clinical follow-up (PMCF) data from devices already on the market
The output is a Clinical Evaluation Report (CER). Under EU MDR, the standard for clinical evidence is significantly higher than under MDD. Literature reviews alone are rarely sufficient for Class IIb or III devices.
Step 7: Engage a Notified Body (for Class IIa, IIb, III)
A Notified Body is an independent EU-designated organisation that assesses whether your device, QMS, and documentation meet EU MDR requirements. They are listed in the NANDO database.
They will review your Technical File, audit your QMS, and issue a CE Certificate of Conformity if everything meets the standard.
Step 8: Perform EUDAMED Registration
EUDAMED (European Database on Medical Devices) is the EU’s central registry for medical devices. Registration is mandatory under EU MDR. You must register your company as an ‘Economic Operator’, register your devices with their UDI (Unique Device Identification), and submit Safety and Performance summaries.
Step 9: Sign the Declaration of Conformity
The Declaration of Conformity (DoC) is the manufacturer’s legal statement that the device meets all applicable EU MDR requirements. You — the manufacturer — sign it. It must include: device identification, list of applicable standards and regulations, Notified Body name and certificate number (if applicable), and the name and signature of the authorised signatory.
Step 10: Affix CE Mark and Place on Market
Apply the CE mark to the device, its packaging, and any accompanying documents. The mark must be at least 5mm tall. For devices requiring a Notified Body, the 4-digit NB identification number follows immediately after the CE mark.
You can now legally distribute your device across 27 EU member states plus Norway, Iceland, Liechtenstein, and Switzerland.
Step 11: Post-Market Surveillance (Ongoing)
CE marking does not end at market launch. EU MDR requires continuous post-market surveillance throughout the lifecycle of your device.
- Post-Market Clinical Follow-up (PMCF) — ongoing clinical data collection
- Periodic Safety Update Report (PSUR) — for Class IIa, IIb, III
- Annual Safety Update Report (ASUR) — for Class IIa devices
- Serious Incident reporting within 2 hours (immediate) to 15 days depending on severity
- Field Safety Corrective Actions (FSCAs) when needed
- Trend reporting for non-serious incidents
10 Common CE Marking Mistakes That Delay or Kill Applications
These are the real-world errors that regulatory consultants and Notified Bodies see most often. Knowing them in advance can save you 12+ months and thousands of euros.
- Misclassifying the device — Using MDD classification rules instead of EU MDR Annex VIII. These are not the same. Some Class IIa devices under MDD are now Class IIb under EU MDR.
- Thin clinical evidence — Assuming a literature review is enough. Under EU MDR, the clinical evidence bar is significantly higher, especially for implantable and Class III devices. Identify your clinical strategy before writing your Technical File.
- Generic risk management — Copying ISO 14971 templates without device-specific risk analysis. Notified Bodies can spot a copied risk file within minutes. Your hazards, harms, and risk controls must reflect your actual device.
- Weak GSPR checklist — The General Safety and Performance Requirements checklist (Annex I) must map every requirement to specific evidence. Vague entries like ‘see design file’ are not accepted.
- Ignoring post-market obligations — CE marking is an ongoing commitment. Many manufacturers set up great systems to get the CE mark, then neglect PMS, PMCF, and incident reporting once on the market — risking certificate withdrawal.
- Choosing the wrong Notified Body — Not every Notified Body is approved for every device type under EU MDR. Check the NANDO database before engaging one.
- Not appointing an EU AR early enough — The EU AR must be registered in EUDAMED before your device can be registered. Delay here creates a bottleneck.
- UDI implementation errors — Incorrect UDI-DI or UDI-PI structure, using the wrong issuing entity (GS1 vs HIBCC), or late EUDAMED upload. These create compliance gaps and can delay market entry.
- IFU not in all required languages — Instructions for Use must be available in the official languages of every EU member state where you sell the device. This is frequently missed for smaller markets.
- Treating CE marking as a one-time project — The biggest mistake. CE marking under EU MDR is a continuous regulatory commitment, not a certificate you get and forget. Budget for ongoing QMS maintenance, PMCF, and surveillance activities.
CE Marking vs FDA Approval: What Indian Manufacturers Need to Know
Many Indian manufacturers ask: should I pursue CE marking or FDA approval first? Here is an honest, practical comparison — not a generic table.
| Factor | CE Marking (EU MDR) | FDA Approval (USA) |
|---|---|---|
| Market covered | 27 EU states + EEA (Norway, Iceland, Liechtenstein) + Switzerland — access to 450M+ consumers | United States only — 330M consumers |
| Governing body | European Commission + Notified Bodies (private sector, EU-designated) | FDA — US government agency |
| Regulation | EU MDR 2017/745 (medical devices), EU IVDR 2017/746 (IVDs) | 21 CFR, FD&C Act, FDA guidance documents |
| Pathway (low-risk) | Self-declaration (Class I) — no independent review needed | 510(k) submission — FDA review required (3–12 months) |
| Pathway (high-risk) | Notified Body + clinical evidence (Class IIa–III) | PMA (Premarket Approval) — very rigorous, 1–5 years |
| Clinical evidence | Clinical Evaluation Report (CER) — can use existing literature for some classes | Clinical trials typically required for high-risk devices |
| Cost comparison | Generally lower for Class I–IIa; comparable to FDA for Class III | Generally higher across most device categories |
| Timeline | 3 months (Class I) to 5 years (Class III) | 6 months (510k, simple) to 5+ years (PMA) |
| Other markets that accept it | UAE, Australia, Canada (partial), Israel, Singapore, Turkey recognise CE for some pathways | Limited mutual recognition outside USA |
| Post-market obligations | Very strong — PSURs, PMCF, EUDAMED reporting, UDI | MDR reporting, 510(k) supplement for changes |
Our recommendation for Indian manufacturers: pursue CE marking first. It typically has a faster path to market for Class I and IIa devices, opens the door to 50+ countries that recognise the CE mark, and builds the clinical documentation you will need for FDA submissions anyway.
ISO 13485 and CE Marking: What Is the Real Connection?
There is a common misconception: getting ISO 13485 does not automatically give you CE marking, and CE marking does not require ISO 13485 by law. But in practice, they are inseparable.
| Topic | Explanation |
|---|---|
| What ISO 13485 covers | It is a Quality Management System (QMS) standard specifically for medical device design and manufacturing. It governs design controls, supplier management, traceability, complaint handling, and CAPA processes. |
| Is it required for CE? | Not as a legal mandate for all device classes. But all Notified Bodies require it for Class IIa+ devices, it is expected by most EU distributors, and it is legally required in Canada (MDSAP) and highly recommended for global market access. |
| How it accelerates CE | A well-implemented QMS means your Technical File documentation, risk records, and clinical evidence are already structured per international standards. Notified Body audits go faster. Deficiencies are fewer. Re-certification costs drop. |
| Cost of not having it | Without a QMS, your Technical File often lacks systematic evidence. Notified Bodies issue major non-conformances. Corrective action cycles can add 6–18 months to your CE timeline. |
| Scope matters | Your ISO 13485 scope must match your product portfolio. A certificate for 'surgical instruments' may not cover you for a new Class IIb electrosurgical device. |
CE Marking Cost and Timeline: Realistic Numbers (Not Estimates)
Most guides give you a range like ‘EUR 5,000 to 500,000’ which is not very helpful. Here is a more detailed breakdown of where the money actually goes:
| Cost Component | Class I | Class IIa | Class IIb | Class III |
|---|---|---|---|---|
| QMS / ISO 13485 setup | EUR 3,000–8,000 | EUR 5,000–15,000 | EUR 8,000–20,000 | EUR 15,000–40,000 |
| Technical File preparation | EUR 2,000–6,000 | EUR 8,000–25,000 | EUR 15,000–45,000 | EUR 30,000–120,000 |
| Clinical Evaluation Report (CER) | EUR 1,000–4,000 | EUR 5,000–20,000 | EUR 15,000–50,000 | EUR 40,000–150,000+ |
| Notified Body fees | Not required | EUR 10,000–30,000 | EUR 20,000–60,000 | EUR 50,000–200,000+ |
| Testing & biocompatibility | EUR 1,000–5,000 | EUR 3,000–15,000 | EUR 10,000–40,000 | EUR 20,000–80,000 |
| EUDAMED & EU AR setup | EUR 1,000–3,000 | EUR 1,500–4,000 | EUR 2,000–5,000 | EUR 3,000–8,000 |
| TOTAL RANGE | EUR 8,000–26,000 | EUR 32,500–109,000 | EUR 70,000–220,000 | EUR 158,000–598,000+ |
| Timeline | 3 – 6 months | 9 – 18 months | 12 – 24 months | 2 – 5 years |
Real Case Study: How a Pune-Based Manufacturer Got CE Marking in 11 Months
Case Study: Class IIa Orthopaedic Support Device — Pune, Maharashtra
Background
A mid-size Pune-based manufacturer of orthopaedic knee braces and support devices wanted to export to Germany and the Netherlands. Their devices were Class IIa under EU MDR — meaning a Notified Body was required. They had existing ISO 9001 certification but no medical device QMS. They had never dealt with EU regulations before.
Challenges They Faced
- ISO 9001 had to be entirely replaced with ISO 13485 — different scope, different documentation structure.
- They had zero clinical evidence. Their devices had been sold in India without formal clinical data.
- No EU Authorized Representative. No knowledge of EUDAMED.
- One product line had three device variants — each needed separate classification and documentation.
What They Did (Month-by-Month)
Months 1–2: ISO 13485 gap analysis and QMS restructuring. Design controls, risk management, and complaint handling procedures built from scratch.
Months 2–4: Technical File compilation for all three variants. GSPR checklist mapped. Systematic literature review conducted for the CER — 34 clinical papers reviewed.
Month 3: EU Authorized Representative appointed in the Netherlands. EUDAMED operator registration submitted.
Month 5: ISO 13485 certification audit passed first attempt. Notified Body application submitted.
Months 6–9: Notified Body technical documentation review. Two rounds of queries responded to. One minor QMS non-conformance corrected.
Months 10–11: CE Certificate of Conformity issued. Declaration of Conformity signed. CE mark affixed. EUDAMED device registration completed.
Results
Full CE marking achieved in 11 months — below the typical 12–18 month timeline for Class IIa. In the first year of EU sales, the company generated EUR 180,000 in revenue from two German distributors. The CE mark also helped them enter the UAE market (which accepts CE-certified devices) without additional regulatory filings.
The single biggest factor in their success:
Starting the ISO 13485 QMS and the Clinical Evaluation Report simultaneously, rather than sequentially. This parallel approach saved approximately 4 months.
What Changed Under EU MDR 2017/745? (vs. Old MDD)
If your device had CE marking under the old Medical Device Directive (MDD 93/42/EEC), you need to understand what is different under EU MDR. The differences are substantial.
| Area | What Changed Under EU MDR |
|---|---|
| Clinical Evidence | Literature reviews alone are often insufficient. Manufacturers must provide more robust clinical data, including PMCF plans for ongoing evidence collection post-market. |
| Classification | Many device types moved to higher risk classes. Rule 9 changes affected reusable surgical instruments significantly. |
| EUDAMED | New mandatory EU database for all economic operators, devices, certificates, clinical investigations, and vigilance events. |
| UDI System | Mandatory Unique Device Identification system for all devices, enabling full traceability across the supply chain. |
| QMS Requirements | More detailed QMS requirements including explicitly required procedures for implant cards, SSCP, and PMCF. |
| Notified Body Oversight | Stricter designation criteria for Notified Bodies. Fewer are designated under EU MDR — creating capacity bottlenecks. |
| Implant Cards | Mandatory for all implantable Class III devices. Must be provided to patients at the time of implantation. |
| Post-Market Surveillance | More rigorous requirements: PSURs (annually for Class III, every 2 years for IIb, every 3 for IIa), proactive PMCF plans. |
| Authorised Representative Liability | EU ARs now have joint and several liability with manufacturers — significantly increasing their responsibilities. |
| Transition Deadlines | All legacy MDD CE certificates expired by 31 May 2024 unless renewed under EU MDR. Devices that were on the market may still be sold by distributors until May 2025 if conditions are met. |
CE Compliance Checklist for Medical Device Manufacturers
Use this checklist to assess your readiness before engaging a Notified Body or investing in a full CE marking programme:
Pre-Application Readiness
- Device classified correctly under EU MDR Annex VIII
- Intended purpose defined precisely in writing
- Target population and indications for use documented
- All applicable harmonized standards identified
- EU Authorized Representative identified (for non-EU manufacturers)
QMS & Documentation
- ISO 13485:2016 QMS implemented or in process
- Design and development procedures established
- Supplier qualification and control system in place
- Non-conformance, CAPA, complaint handling procedures documented
- Internal audit programme planned
Technical Documentation
- Technical File structure planned (Annexes II and III of EU MDR)
- GSPR checklist (Annex I) started with evidence mapping
- Risk management file initiated per ISO 14971
- Clinical evaluation strategy defined (literature vs. clinical data)
- CER outline and literature search protocol ready
- Labelling and IFU drafted in required EU languages
Market Entry
- Notified Body selected and application timeline planned
- EUDAMED operator registration initiated
- UDI-DI and UDI-PI assigned through GS1 or HIBCC
- Post-Market Surveillance plan drafted
- PMCF plan drafted for Class IIa and above
- Declaration of Conformity template prepared
How Traccglobal Helps Indian Manufacturers Get CE Marking
Getting CE marking from India involves navigating EU regulations, finding the right Notified Body, building an ISO 13485 QMS, preparing clinical evidence, appointing an EU AR, and managing EUDAMED — all while running your manufacturing business.
Traccglobal is a regulatory and legal compliance firm with 10+ years of experience helping Indian businesses achieve international certifications including ISO 13485, CE marking, and EU MDR compliance. We have worked with manufacturers in medical devices, surgical instruments, diagnostics, and healthcare equipment.
What We Handle for You
- Device classification review and regulatory pathway strategy
- ISO 13485 QMS gap analysis, documentation, and certification support
- Technical File preparation and GSPR checklist completion
- Clinical Evaluation Report (CER) writing and literature review support
- EU Authorized Representative coordination
- Notified Body selection, application preparation, and audit support
- EUDAMED registration and UDI implementation guidance
- Post-Market Surveillance plan and PMCF design
Our in-house team at Traccglobal handles advanced regulatory strategy for complex Class IIb and Class III medical device pathways, bringing deep clinical affairs expertise for devices requiring full clinical investigations and robust post-market evidence.
Frequently Asked Questions About CE Marking for Medical Devices
Q: What is CE marking for medical devices and why is it required?
CE marking for medical devices is a mandatory regulatory certification required to sell any medical device in the European Union. It proves the device meets EU safety, performance, and health protection requirements under EU MDR 2017/745. Without a CE mark, a device cannot legally enter the EU market — customs authorities actively block non-compliant products.
Q: What does CE stand for in medical devices?
CE stands for Conformité Européenne, French for ‘European Conformity.’ In medical contexts, CE meaning confirms that the device complies with all applicable EU safety and performance regulations. It is a legal market access requirement, not a quality award. It does not indicate that the device is the highest quality — only that it meets the minimum required EU standards.
Q: How long does CE marking take for a medical device?
CE marking timelines vary by device class. Class I devices with self-declaration take 3 to 6 months. Class IIa devices requiring a Notified Body typically take 9 to 18 months. Class IIb devices take 12 to 24 months. High-risk Class III devices can take 2 to 5 years. Preparation quality and Notified Body queue times are the main factors affecting timeline.
Q: How much does CE marking cost for a medical device?
CE marking costs depend on device class. Class I self-declaration devices cost roughly EUR 8,000 to 26,000 including QMS setup and documentation. Class IIa devices range from EUR 32,000 to 110,000. Class IIb ranges from EUR 70,000 to 220,000. Class III can exceed EUR 600,000. Ongoing post-market obligations add EUR 5,000 to 20,000 per year after certification.
Q: What is the difference between CE marking and EU MDR certification?
CE marking is the physical mark on your device indicating EU compliance. EU MDR (Medical Device Regulation 2017/745) is the legal framework under which that CE mark is granted. Getting EU MDR certification means your device, QMS, and documentation have passed the conformity assessment process required by EU MDR. The CE mark is the visible outcome; EU MDR is the process.
Q: Is ISO 13485 required to get CE marking for medical devices?
ISO 13485 is not legally mandatory for all CE marking applications, but it is practically required for any device needing Notified Body involvement (Class IIa, IIb, and III). Notified Bodies expect an ISO 13485-compliant QMS as part of their conformity assessment. For Class I self-declaration devices, ISO 13485 is not legally required but strongly recommended to structure documentation correctly.
Q: Can an Indian company directly apply for CE marking without a European office?
Yes, Indian companies can get CE marking without a European office, but they must appoint an EU Authorized Representative legally registered in an EU member state. This representative handles EUDAMED registration and acts as the regulatory contact for EU authorities. Selling in the EU without an appointed EU AR is illegal for non-EU manufacturers, regardless of the device’s CE mark status.
Q: What is a Notified Body for medical devices and how do I choose one?
A Notified Body is an independent organisation designated by an EU member state to assess medical devices against EU MDR requirements. They issue CE Certificates of Conformity for Class IIa, IIb, and III devices. Choose one from the official NANDO database that is specifically designated for your device type under EU MDR. Well-known ones include TUV SUD, BSI, SGS, and Bureau Veritas.
Q: What documents are needed for CE marking of a medical device?
Key documents for CE marking include: Technical File (device description, design info, risk management file, clinical evaluation report, labelling), GSPR checklist, ISO 13485 QMS documentation, Post-Market Surveillance plan, Instructions for Use in required EU languages, and a signed Declaration of Conformity. Class III devices also require a Summary of Safety and Clinical Performance (SSCP) published on EUDAMED.
Q: What happens if I sell a medical device in the EU without CE marking?
Selling a medical device in the EU without CE marking is illegal and carries serious consequences: product seizure by customs or market surveillance authorities, financial penalties, bans on future EU market entry, potential criminal liability, and product liability lawsuits if patient harm results. EU authorities actively monitor imports and conduct post-market surveillance checks on devices already in distribution.
Q: What is the difference between CE marking under old MDD and new EU MDR?
EU MDR 2017/745 requires substantially more clinical evidence, introduces mandatory EUDAMED registration, a new UDI traceability system, stricter post-market surveillance obligations, and reclassified many devices to higher-risk categories. MDD CE certificates expired by May 2024. All new devices and renewals must now comply with EU MDR, which has higher documentation and clinical standards than MDD.
Q: How do I start the CE marking process for my medical device?
Start with device classification under EU MDR Annex VIII — this determines your entire regulatory pathway and cost. Then identify applicable harmonized standards, begin ISO 13485 QMS implementation, and appoint an EU Authorized Representative if you are outside the EU. Start your Clinical Evaluation Report early — it is the most time-consuming document. Engage a Notified Body once your documentation is substantially complete.
Start Your CE Marking Journey with Expert Guidance
CE marking for medical devices is complex, time-consuming, and high-stakes. But with the right guidance, even first-time applicants can navigate it efficiently.
Whether you are classifying your device for the first time, rebuilding documentation after an MDD-to-MDR transition, or looking to fix a failing Notified Body audit — DMS Legal World is ready to help.
We have supported manufacturers of surgical instruments, orthopaedic devices, diagnostics, patient monitoring equipment, and wound care products through the full CE marking process.
Our Services
Let Us Know Your Requirements
Call Emergency
+918868886774
What Our Clients Says
Real feedback from our happy clients about our quality and service.
